Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR2 | P41597 | 3/20 | 0.40 |
| ▸ | CCR1 | P32246 | 1/20 | 0.40 |
| ▸ | CCR5 | P51681 | 1/20 | 0.40 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | ACAT1 | P24752 | 1/20 | 0.40 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.40 |
| ▸ | CNR1 | P21554 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | DRD2 | P14416 | 1/20 | 0.37 |
| ▸ | DRD4 | P21917 | 1/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8632431 | 0.93 | CCR2 (0.46) | CCR2CCR1CCR5CXCR4KDM4E | |
| SCHEMBL23812164 | 0.91 | CCR2 (0.48) | CCR2CCR1CCR5CXCR4KDM4E | |
| SCHEMBL13036470 | 0.86 | MEN1 (0.47) | CCR2CCR1CCR5CXCR4KDM4E | |
| SCHEMBL4431635 | 0.82 | CA1 (0.41) | CCR2CCR1CCR5CXCR4KDM4E | |
| SCHEMBL17447494 | 0.81 | CNR1 (0.42) | CCR2CCR1CCR5CXCR4KDM4E | |
| SCHEMBL12064065 | 0.78 | ALDH1A1 (0.34) | CCR2CCR1CCR5CXCR4KDM4E | |
| SCHEMBL22084111 | 0.78 | EPHX1 (0.34) | EPHX1ALDH1A1FDPS | |
| SCHEMBL22828907 | 0.78 | ALDH1A1 (0.38) | MEN1KMT2ATDP1EPHX1ALDH1A1 | |
| SCHEMBL16925399 | 0.78 | MAPT (0.38) | CCR2CCR1CCR5CXCR4KDM4E | |
| SCHEMBL22317358 | 0.78 | CNR1 (0.47) | CCR2CCR1CCR5CXCR4KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3082877-B1 | CYTOTOXIC PEPTIDES AND CONJUGATES THEREOF | NOVARTIS AG (CH) | 2019-08-28 | — | — | EP | disclosed |
| US-20170210734-A1 | Substituted Azaspiro(4.5)Decane Derivatives | GRUENENTHAL GMBH (DE) | 2017-07-27 | — | — | US | disclosed |
| WO-2016008582-A1 | SUBSTITUTED AZASPIRO(4.5)DECANE DERIVATIVES | Grünenthal GmbH (DE) | 2016-01-21 | — | — | WO | disclosed |
| EP-1951664-A1 | ORGANIC SULFUR COMPOUNDS AND USE THEREOF AS ARTHROPODICIDES | Sumitomo Chemical Company, Limited (JP) | 2008-08-06 | — | — | EP | disclosed |
| WO-2007060839-A1 | ORGANIC SULFUR COMPOUNDS AND USE THEREOF AS ARTHROPODICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170210734-A1 | Substituted Azaspiro(4.5)Decane Derivatives | OPRL1, OPRM1, OPRD1 | CCR2 601/4885CCR1 703/4885CCR5 254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.